CINXE.COM

The Black Box Effect - How Can AI and ML Provide Transparent Insights for Drug Discovery?

<!doctype html><html lang="en"><head> <meta charset="utf-8"> <title>The Black Box Effect - How Can AI and ML Provide Transparent Insights for Drug Discovery?</title> <link rel="shortcut icon" href="https://oxfordglobal.com/hubfs/OXFORD_GLOBAL-LOGO_SYMBOL.jpg"> <meta name="description" content="The Black Box Effect is a controversial topic in drug discovery, often raising questions about the feasibility of machine learning."> <meta name="viewport" content="width=device-width, initial-scale=1"> <meta property="og:description" content="The Black Box Effect is a controversial topic in drug discovery, often raising questions about the feasibility of machine learning."> <meta property="og:title" content="The Black Box Effect - How Can AI and ML Provide Transparent Insights for Drug Discovery?"> <meta name="twitter:description" content="The Black Box Effect is a controversial topic in drug discovery, often raising questions about the feasibility of machine learning."> <meta name="twitter:title" content="The Black Box Effect - How Can AI and ML Provide Transparent Insights for Drug Discovery?"> <style> a.cta_button{-moz-box-sizing:content-box !important;-webkit-box-sizing:content-box !important;box-sizing:content-box !important;vertical-align:middle}.hs-breadcrumb-menu{list-style-type:none;margin:0px 0px 0px 0px;padding:0px 0px 0px 0px}.hs-breadcrumb-menu-item{float:left;padding:10px 0px 10px 10px}.hs-breadcrumb-menu-divider:before{content:'›';padding-left:10px}.hs-featured-image-link{border:0}.hs-featured-image{float:right;margin:0 0 20px 20px;max-width:50%}@media (max-width: 568px){.hs-featured-image{float:none;margin:0;width:100%;max-width:100%}}.hs-screen-reader-text{clip:rect(1px, 1px, 1px, 1px);height:1px;overflow:hidden;position:absolute !important;width:1px} </style> <link rel="stylesheet" href="https://oxfordglobal.com/hs-fs/hub/8696823/hub_generated/template_assets/135726131582/1732113079147/git/og-stage/css/main.min.css"> <link rel="stylesheet" href="https://cdn.oxfordglobal.com/fontawesome/6.5.1/css/fontawesome.min.css"> <link rel="stylesheet" href="https://cdn.oxfordglobal.com/fontawesome/6.5.1/css/brands.min.css"> <link rel="stylesheet" href="https://cdn.oxfordglobal.com/fontawesome/6.5.1/css/solid.min.css"> <!-- Editor Styles --> <style id="hs_editor_style" type="text/css"> #hs_cos_wrapper_module_17019620504109 { display: block !important; margin-bottom: 0px !important } </style> <!-- Added by GoogleAnalytics4 integration --> <script> var _hsp = window._hsp = window._hsp || []; window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} var useGoogleConsentModeV2 = true; var waitForUpdateMillis = 1000; if (!window._hsGoogleConsentRunOnce) { window._hsGoogleConsentRunOnce = true; gtag('consent', 'default', { 'ad_storage': 'denied', 'analytics_storage': 'denied', 'ad_user_data': 'denied', 'ad_personalization': 'denied', 'wait_for_update': waitForUpdateMillis }); if (useGoogleConsentModeV2) { _hsp.push(['useGoogleConsentModeV2']) } else { _hsp.push(['addPrivacyConsentListener', function(consent){ var hasAnalyticsConsent = consent && (consent.allowed || (consent.categories && consent.categories.analytics)); var hasAdsConsent = consent && (consent.allowed || (consent.categories && consent.categories.advertisement)); gtag('consent', 'update', { 'ad_storage': hasAdsConsent ? 'granted' : 'denied', 'analytics_storage': hasAnalyticsConsent ? 'granted' : 'denied', 'ad_user_data': hasAdsConsent ? 'granted' : 'denied', 'ad_personalization': hasAdsConsent ? 'granted' : 'denied' }); }]); } } gtag('js', new Date()); gtag('set', 'developer_id.dZTQ1Zm', true); gtag('config', 'G-43QK8SYTST'); </script> <script async src="https://www.googletagmanager.com/gtag/js?id=G-43QK8SYTST"></script> <!-- /Added by GoogleAnalytics4 integration --> <link rel="canonical" href="https://oxfordglobal.com/nextgen-biomed/resources/the-black-box-effect"> <meta property="og:image" content="https://oxfordglobal.com/hubfs/Website/Images/Resources/Biologics/The-Black-Box-Effect-in-Drug-Discovery-scaled.jpg"> <meta name="twitter:image" content="https://oxfordglobal.com/hubfs/Website/Images/Resources/Biologics/The-Black-Box-Effect-in-Drug-Discovery-scaled.jpg"> <meta property="og:url" content="https://oxfordglobal.com/nextgen-biomed/resources/the-black-box-effect"> <meta name="twitter:card" content="summary"> <meta http-equiv="content-language" content="en"> <meta name="generator" content="HubSpot"></head> <body class="nextgen-biomed"> <div class="body-wrapper hs-content-id-177607186815 hs-site-page page "> <div data-global-resource-path="git/og-stage/templates/partials/header.html"> <header class="website-header "> <div class="navbar"> <div class="navbar-brands"> <a href="/nextgen-biomed" class="logo-link current-brand"> <img src="https://oxfordglobal.com/hubfs/Website/Logos/Brand%20Logos/NextGen%20Biomed.svg" class="logo-image"> <i class="dropdown fa-solid fa-chevron-down"></i> </a> <div class="brands"> <div class="intro"> <h2> Explore our brands </h2> <div class="desc"> Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&amp;D trends and challenges. </div> </div> <div class="items"> <div class="item primary-brand"> <a href="/" class="logo-link"><img src="https://oxfordglobal.com/hubfs/logo.jpg" class="logo-image"></a> </div> <div class="item"> <a href="/precision-medicine" class="logo-link"><img src="https://oxfordglobal.com/hubfs/Website/Logos/Brand%20Logos/Precision%20Medicine.svg" class="logo-image"></a> </div> <div class="item"> <a href="/discovery-development" class="logo-link"><img src="https://oxfordglobal.com/hubfs/Website/Logos/Brand%20Logos/Discovery%20%26%20Development.svg" class="logo-image"></a> </div> <div class="item active-item"> <a href="/nextgen-biomed" class="logo-link"><img src="https://oxfordglobal.com/hubfs/Website/Logos/Brand%20Logos/NextGen%20Biomed.svg" class="logo-image"></a> </div> </div> </div> </div> <div class="flex flex-align-center navbar-nav"> <a href="#" class="navbar-nav-toggle"> <div class="toggle-icons"> <i class="fa-solid fa-bars toggle-open"></i> <i class="fa-solid fa-xmark toggle-close"></i> </div> </a> <ul class="navbar-nav-items"> <li class="navbar-nav-item"> <a href="#" class="navbar-nav-item-link">Events <i class="fa-solid fa-chevron-down"></i></a> <div class="navbar-subnav"> <div class="subnav-graphics"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Header%20Events.jpg" class="subnav-image"> </div> <div class="subnav-items"> <div class="subnav-item flex-3 divider g-20"> <div class="subnav-item-content bottom-mp-fix"> <h3> In-Person &amp; Online Events </h3> <p>Pivotal moments where high-level industry experts and thought leaders come together for focused knowledge sharing and unparalleled networking opportunities.</p> </div> <div class="subnav-item"> <div class="event-pills"> <a href="/nextgen-biomed/events/nextgen-biomed-2025" class="pill center"> <div class="b">NextGen Biomed 2025</div> <div class="heading-smallcaps"> 12 - 14 Mar 2025 | London, UK </div> </a> <a href="/nextgen-biomed/events/cell-2025" class="pill center"> <div class="b">Cell 2025</div> <div class="heading-smallcaps"> 11-12 Nov 2025 | London, UK </div> </a> </div> </div> </div> <div class="subnav-item flex-2"> <div class="subnav-item-content bottom-mp-fix"> <h3> Online Activities </h3> <p>Our Monthly Science Exchanges and Webinars keep you connected to the conversation.</p> </div> <div class="online-activities-list flex flex-column g-10"> <!-- Individual Online Activity --> <div class="online-activity"> <a href="/nextgen-biomed/online#Process%20Challenges%20in%20ATMP%20Development:%20Overcoming%20Hurdles%20for%20Successful%20Manufacturing" class="cta" target="_blank"> <h3 class="other-resources">01/11/24 - Process Challenges in ATMP Development: Overcoming Hurdles for Successful Manufacturing</h3> </a> </div> </div> <div class="subnav-item-content-more"> <a href="/nextgen-biomed/online" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> All Online Activities</a> </div> </div> </div> </div> </li> <li class="navbar-nav-item"> <a href="#" class="navbar-nav-item-link">Community <i class="fa-solid fa-chevron-down"></i></a> <div class="navbar-subnav"> <div class="subnav-graphics"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Header%20Community.jpg" class="subnav-image"> </div> <div class="subnav-items"> <div class="subnav-item flex flex-1 divider"> <div class="subnav-item-content bottom-mp-fix"> <h3> About </h3> <p>NextGen Biomed is the platform to advance the fields of biologics, vaccines &amp; novel therapeutics approaches, helping to deliver life-saving medicines to patients faster.</p> </div> <div class="subnav-item-content-more"> <a href="/nextgen-biomed/about" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> More Info</a> </div> </div> <div class="subnav-item flex flex-1 divider"> <div class="subnav-item-content bottom-mp-fix"> <h3> Community </h3> <p>NextGen Biomed is committed to supporting R&amp;D scientists, as well as drug development and manufacturing experts, working with biologics, peptides, and oligonucleotides to overcome complexities at every stage of the drug product lifecycle.</p> </div> <div class="subnav-item-content-more"> <a href="/nextgen-biomed/community" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> More Info</a> </div> </div> <div class="subnav-item flex flex-1 "> <div class="subnav-item-content bottom-mp-fix"> <h3> Media Partners </h3> <p>We work with leading journal publications on reciprocal marketing arrangements.</p> </div> <div class="subnav-item-content-more"> <a href="/nextgen-biomed/media-partners" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> More Info</a> </div> </div> </div> </div> </li> <li class="navbar-nav-item"> <a href="#" class="navbar-nav-item-link">Services <i class="fa-solid fa-chevron-down"></i></a> <div class="navbar-subnav"> <div class="subnav-graphics"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Header%20Services.jpg" class="subnav-image"> </div> <div class="subnav-items"> <div class="subnav-item flex flex-1 divider"> <div class="subnav-item-content bottom-mp-fix"> <h3> In-Person Services </h3> <p>At Oxford Global, our events are designed to connect key life science figures and innovative solution providers, accelerating scientific advancement. Our goal is to create valuable connections and an impactful experience through innovative and collaborative formats.</p> </div> <div class="subnav-item-content-more"> <a href="/nextgen-biomed/in-person-services" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> More Info</a> </div> </div> <div class="subnav-item flex flex-1"> <div class="subnav-item-content bottom-mp-fix"> <h3> Digital Marketing Services </h3> <p>Oxford Global’s products offer a powerful channel to associate your brand with the latest advancements within the industry whilst educating and influencing the industry throughout their buying process.</p> </div> <div class="subnav-item-content-more"> <a href="/nextgen-biomed/digital-marketing-services" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> More Info</a> </div> </div> </div> </div> </li> <li class="navbar-nav-item"> <a href="#" class="navbar-nav-item-link">Resources <i class="fa-solid fa-chevron-down"></i></a> <div class="navbar-subnav"> <div class="subnav-graphics"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Header%20Resources.jpg" class="subnav-image"> </div> <div class="subnav-items"> <div class="subnav-item flex-2 divider"> <div class="subnav-item-content bottom-mp-fix"> <h3> Browse All Resources </h3> <p>The latest in from nextgen biomed research &amp; development</p> </div> <div class="subnav-item-content-more"> <a href="/nextgen-biomed/resources" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> All NextGen Biomed Resources</a> </div> </div> <div class="subnav-item flex-4 divider"> <div class="subnav-item-content bottom-mp-fix"> <h3> Latest Resources </h3> <div class="resources"> <div class="resource"> <div class="resource-cover"> <a href="/nextgen-biomed/resources/university-college-london-hospitals-begins-clinical-trial-for-one-off-car-t-treatment-for-lupus" class="resource-cover-link"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Resources/NextGen%20Biomed/University%20College%20London%20Hospitals%20Begins%20Clinical%20Trial%20for%20One-Off%20CAR%20T%20Treatment%20for%20Lupus%201.jpg" class="resource-cover-image"> </a> </div> <div class="resource-content"> <h3 class="resource-heading"> <a href="/nextgen-biomed/resources/university-college-london-hospitals-begins-clinical-trial-for-one-off-car-t-treatment-for-lupus">University College London Hospitals Begins Clinical Trial for One-Off CAR T Treatment for Lupus</a> </h3> <div class="resource-abstract"> <span class="resource-date">08/11/24 - </span> The possibility of a one-off treatment for lupus could offer hope to 69,000 patients in the UK. </div> </div> </div> <div class="top-divider"></div> <div class="resource"> <div class="other-resources"><a href="/nextgen-biomed/resources/clesrovimab-shows-positive-results-as-preventative-treatment-for-rsv-in-pre-term-and-full-term-infants">07/11/24 - Clesrovimab Shows Positive Results as Preventative Treatment for RSV in Pre-Term and Full-Term Infants</a></div> </div> <div class="top-divider"></div> <div class="resource"> <div class="other-resources"><a href="/nextgen-biomed/resources/the-nist-awards-1-5-million-to-improve-standardisation-in-regenerative-medicine">31/10/24 - The NIST Awards $1.5 Million to Improve Standardisation in Regenerative Medicine</a></div> </div> </div> </div> </div> <div class="subnav-item flex-3"> <div class="subnav-item-content bottom-mp-fix"> <h3> Featured Resource </h3> <div class="resources flex flex-column g-5"> <a href="https://oxfordglobal.com/nextgen-biomed/resources/sponsored/webinar/wuxibiologics/sp-webinar-optimizing-bispecific-antibody-production-from-identifying-optimal-pairings-to-scale-up-processes"> <div class="sponsor-resource flex-column"> <div class="resource-cover img-fluid"> <div class="sponsor-resource-cover-link"> <img src="https://oxfordglobal.com/hubfs/Digital%20Marketing/Webinars/Email%20and%20Social%20Collateral/NGB%20-%20Wuxi%20Biologics/WuXi%20Biologics.png" class="sponsor-resource-cover-image"> </div> </div> <div class="resource-content p-15"> <h3 class="resource-heading"> Optimizing Bispecific Antibody Production: From Identifying Optimal Pairings to Scale-up Processes </h3> <div class="resource-abstract"> On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics </div> </div> </div> </a> </div> </div> </div> </div> </div> </li> <li class="navbar-nav-item show-sm hide-md hide-lg hide-xl"> <a href="javascript:postMessage({type:'HS_DISPLAY_CALL_TO_ACTION',id:130207947529});" class="navbar-nav-item-link">Contact</a> </li> <li class="navbar-nav-item show-sm hide-md hide-lg hide-xl"> <a href="#" class="navbar-nav-item-link">Our Brands <i class="fa-solid fa-chevron-down"></i></a> <div class="navbar-subnav"> <div class="subnav-items"> <h2> Explore our brands </h2> <div class="desc"> Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&amp;D trends and challenges. </div> <div class="subnav-item"> <div class="subnav-item-content"> <a href="/">Oxford Global</a> </div> </div> <div class="subnav-item"> <div class="subnav-item-content"> <a href="/precision-medicine">Precision Medicine</a> </div> </div> <div class="subnav-item"> <div class="subnav-item-content"> <a href="/discovery-development">Discovery &amp; Development</a> </div> </div> <div class="subnav-item"> <div class="subnav-item-content"> <a href="/nextgen-biomed">NextGen Biomed</a> </div> </div> </div> </div> </li> </ul> </div> <div class="flex flex-align-center hide-sm show-md show-lg show-xl"> <a href="javascript:postMessage({type:'HS_DISPLAY_CALL_TO_ACTION',id:130207947529});" class="navbar-button">Contact</a> </div> </div> </header></div> <main id="main-content"> <div class="resource-single"> <div class="header bg-primary-light"> <div class="container-wrapper"> <div class="wide-container header-container"> <div class="header-content flex-1"> <div class="heading-smallcaps"> Bioanalysis | Industry Spotlights &amp; Insight Articles </div> <h1 class="heading"> The Black Box Effect - How Can AI and ML Provide Transparent Insights for Drug Discovery? </h1> <div class="byline"> Edited by Tia Byer | 30 August 2022 </div> <div class="abstract"> We interview Martin Akerman, Chief Technology Officer and Co-Founder at Envisagenics to find out about machine learning for drug target discovery in RNA. </div> </div> <div class="header-graphic flex-1"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Resources/Biologics/The-Black-Box-Effect-in-Drug-Discovery-scaled.jpg" class="header-graphic-image"> </div> </div> </div> </div> <div class="container-wrapper"> <div class="wide-container"> <div class="content"> <div class="content-body text-gap"> <!-- wp:paragraph --> <p>In data analysis, the ‘Black Box Effect’ refers to an artificial intelligence (AI) system, device, or program that provides useful information without revealing any information about its internal workings. The explanations for its results and conclusions remain hidden or ‘black.’</p> <!-- /wp:paragraph --> <!-- wp:paragraph --> <p>The Black Box Effect is a controversial and much-discussed topic in drug discovery, often raising questions about the feasibility of machine learning (ML). According to Martin Akerman, Chief Technology Officer and Co-Founder at Envisagenics, this issue becomes a major stumbling block for researchers during the drug discovery phase.</p> <!-- /wp:paragraph --> <!-- wp:list --> <ul><!-- wp:list-item --> <li><a href="https://oxfordglobal.com/biologics/resources/whats-next-for-antibody-based-therapeutic-discovery-and-optimisation/" target="_blank" rel="noreferrer noopener">What’s Next for Antibody-Based Therapeutic Discovery and Optimisation?</a></li> <!-- /wp:list-item --> <!-- wp:list-item --> <li><a href="https://oxfordglobal.com/biologics/resources/computational-engineering-the-future-of-biologics-discovery/" target="_blank" rel="noreferrer noopener">Computational Engineering – the Future of Biologics Discovery?</a></li> <!-- /wp:list-item --> <!-- wp:list-item --> <li><a href="https://oxfordglobal.com/biologics/resources/nature-announces-top-10-rd-institutes/" target="_blank" rel="noreferrer noopener">Nature Announces Top 10 R&amp;D Institutes</a></li> <!-- /wp:list-item --></ul> <!-- /wp:list --> <!-- wp:paragraph --> <p></p> <!-- /wp:paragraph --> <!-- wp:paragraph --> <p>“The Black Box Effect suggests that it's not always easy, relatable, or actionable to work with machine learning when there is an evident lack of understanding about the logic behind such predictions,” he explained. Now, however, this could all change. Envisagenics, an AI-driven RNA therapeutics development company, is working to overcome the Black Box Effect by seeking to optimise the transparency and interpretability of predictive models for drug target discovery in diseases shown to have RNA splicing deregulation.</p> <!-- /wp:paragraph --> <!-- wp:heading {"jetDynamicVisibility":{},"jetEngineDynamicData":{}} --> <h2 class="wp-block-heading">Envisagenics – A Brief History</h2> <!-- /wp:heading --> <!-- wp:paragraph --> <p>Envisagenics was founded in 2014 as a spin-out company from Cold Spring Harbor Laboratory and has a therapeutic area of focus on oncology, neurodegenerative, and metabolic diseases. They specialise in proprietary drug target discovery platforms driven by AI and ML and work with the following therapeutic modalities: antisense oligonucleotides and immunotherapies.</p> <!-- /wp:paragraph --> <!-- wp:image {"align":"center","id":30953,"sizeSlug":"full","linkDestination":"none","jetDynamicVisibility":{}} --> <figure class="wp-block-image aligncenter size-full"><img src="https://oxfordglobal.com/hubfs/Website/Images/Resources/Biologics/The-Black-Box-Effect-with-Martin-Akerman.jpg" alt="The Black Box Effect in Drug Discovery" class="wp-image-30953"><figcaption class="wp-element-caption"><br>Martin Akerman, Chief Technology Officer and Co-Founder at Envisagenics, presenting at Oxford Global's Biologics: In-Person 2022.</figcaption></figure> <!-- /wp:image --> <!-- wp:paragraph --> <p>SpliceCore® is Envisagenics’ proprietary platform, a cloud-based, exon-centric form of AI and ML aimed at accelerating and innovating research and development. The platform is capable of identifying up to 7 million unique splicing events and facilitates the discovery of novel splicing-derived targets. Other functions include designing optimised therapeutics and providing RNA biology insights that were not available before. Notable partnerships have included collaborations with Johnson &amp; Johnson in the field of lung cancer and with Biogen in the area of central nervous system diseases.</p> <!-- /wp:paragraph --> <!-- wp:paragraph --> <p>“At its core, Envisagenics is a drug discovery company,” Akerman explained. This is because “new drug modalities call for new methods of discovering drug targets.” However, because drug development is expensive, there is a pressing need to mitigate risk. Envisagenics aims to achieve this using its target discovery technology that leverages RNA splicing quantification and interpretation. “Our promising AI/ML platform works to improve the drug target innovation rate, which has flattened in recent years,” Akerman added.</p> <!-- /wp:paragraph --> <!-- wp:heading {"jetDynamicVisibility":{},"jetEngineDynamicData":{}} --> <h2 class="wp-block-heading">Component of a Transparent AI Model</h2> <!-- /wp:heading --> <!-- wp:paragraph --> <p>Establishing a hypothesis-driven and predictive testing process is critical for achieving a transparent AI model. “There is a need to build more confidence around AI and reduce the Black Box Effect,” Akerman claimed. “The Envisagenics recipe that we follow to build AI takes this context into account.”</p> <!-- /wp:paragraph --> <!-- wp:paragraph --> <p>To achieve this, Envisagenics focuses on applying target discovery for specific drug modalities. Harnessing a modality-specific focus provides the necessary context for the software and helps to implement domain knowledge as a key component of the predictive engine. Domain knowledge acts as a feedback loop where prior understanding of the targets and their functionalities are incorporated into the model to improve relatability.</p> <!-- /wp:paragraph --> <!-- wp:paragraph --> <p>“The real art comes with trying to transform this biological insight into something that is intuitive and can be translated into an algorithm,” Akerman expressed. But how do you computerise biological information? Whilst many models and approaches rely solely on hypothesis context, Envisagenics incorporates intuitive information into its platform and establishes discrete and quantifiable predictive features.</p> <!-- /wp:paragraph --> <!-- wp:quote {"jetDynamicVisibility":{},"className":"is-style-large"} --> <blockquote class="wp-block-quote is-style-large"><!-- wp:paragraph --> <p>There is a need to build more confidence around AI and reduce the Black Box Effect,” Akerman claimed.</p> <!-- /wp:paragraph --></blockquote> <!-- /wp:quote --> <!-- wp:paragraph --> <p>So far, Envisagenics has been able to computerise and articulate value information such as RNA-protein and protein-protein interactions to identify drug binding sites. Akerman also explained how it is preferable to sacrifice a little bit of predictive accuracy for transparency during digitisation. This is because “if we cannot articulate what the features are showing in the predictive model, it will be even more difficult to interpret them retroactively.”</p> <!-- /wp:paragraph --> <!-- wp:heading {"jetDynamicVisibility":{},"jetEngineDynamicData":{}} --> <h2 class="wp-block-heading" id="h-achieving-results-with-splicecore">Achieving Results with SpliceCore</h2> <!-- /wp:heading --> <!-- wp:paragraph --> <p>Using the SpliceCore platform, Envisagenics has been able to successfully predict splice switching oligonucleotide (SSO) compounds that modulate alternative splicing using molecular interaction data. For this, Envisagenics decided to focus on the spliceosome and investigate its complex structure of networks to uncover “regulatory circuits”, which are the mechanistic units utilised by the spliceosome to regulate splicing.</p> <!-- /wp:paragraph --> <!-- wp:quote {"jetDynamicVisibility":{},"className":"is-style-large"} --> <blockquote class="wp-block-quote is-style-large"><!-- wp:paragraph --> <p>Envisagenics’ SpliceCore technology has identified a novel drug target for triple-negative breast cancer as well as an optimal SSO binding site.</p> <!-- /wp:paragraph --></blockquote> <!-- /wp:quote --> <!-- wp:paragraph --> <p>A total of 32 unique regulatory circuits were pinpointed and leveraged as ML features to predict splicing modulation. This information was then used to predict SSO drug targets, creating a druggability map of antisense oligonucleotides throughout the entire transcriptome. Envisagenics’ SpliceCore technology has identified a novel drug target for triple-negative breast cancer as well as an optimal SSO binding site.</p> <!-- /wp:paragraph --> <!-- wp:paragraph --> <p>By combing ML algorithms to prioritise splicing events and establishing a modular software technique to register regulatory information, Envisagenics was able to actively provide a transparent methodology and reduce the Black Box Effect. “With this outcome, we were able to qualify these assets in the laboratory, which provides great promise for our other ventures in application to drug target discovery,” Akerman said.</p> <!-- /wp:paragraph --> <!-- wp:paragraph --> <p></p> <!-- /wp:paragraph --> <!-- wp:paragraph --> <p><em>Join&nbsp;</em><a href="https://oxfordglobal.com/" target="_blank" rel="noreferrer noopener"><em>Oxford Global’s</em></a><em>&nbsp;annual&nbsp;</em><a href="https://oxfordglobal.com/biologics-series/" target="_blank" rel="noreferrer noopener"><em>Biologics UK: In-Person</em></a><em>&nbsp;event today.&nbsp;This 3-day conference brings together a panel of</em>&nbsp;<em>prominent leaders and scientists, sharing new case studies, innovative data, and exciting industry outlooks.</em></p> <!-- /wp:paragraph --> <div class="content-body-footer"> </div> </div> <div class="content-sidebar"> <div class="related-articles"> <h3 class="center">Related Resources</h3> <div class="article"> <a href="/nextgen-biomed/resources/historic-islet-cell-transplant-offers-hope-of-a-permanent-cure-for-type-1-diabetes"> <div class="cover-graphic"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Resources/Cell%20and%20Gene/reverse%20of%20diabetes%20type%201%20using%20stem%20cells.png" class="cover-graphic-image"> </div> </a><div class="content"><a href="/nextgen-biomed/resources/historic-islet-cell-transplant-offers-hope-of-a-permanent-cure-for-type-1-diabetes"> <h4> Historic Islet Cell Transplant Offers Hope for a Permanent Cure for Type 1 Diabetes </h4> <div class="abstract"> A study led by Professor Deng Hongkui at Peking University successfully treated a type 1 diabetes patient by transplanting insulin-producing islet cells derived from the patient's reprogrammed stem cells. </div> <div class="read-more"> <a href="/nextgen-biomed/resources/historic-islet-cell-transplant-offers-hope-of-a-permanent-cure-for-type-1-diabetes" class="read-more-link">Read More</a> </div></a> </div> </div> <div class="article"> <a href="/nextgen-biomed/resources/lonza-and-vertex-pen-long-term-supply-deal-for-casgevy"> <div class="cover-graphic"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Resources/Biologics/Lonza%20and%20Vertex%20Pen%20Long%20Term%20Supply%20Deal%20for%20CASGEVY.jpg" class="cover-graphic-image"> </div> </a><div class="content"><a href="/nextgen-biomed/resources/lonza-and-vertex-pen-long-term-supply-deal-for-casgevy"> <h4> Lonza and Vertex Pen Long Term Supply Deal for CASGEVY </h4> <div class="abstract"> Lonza will provide scientific, regulatory and manufacturing capabilities to Vertex, as well as use of their global manufacturing network. </div> <div class="read-more"> <a href="/nextgen-biomed/resources/lonza-and-vertex-pen-long-term-supply-deal-for-casgevy" class="read-more-link">Read More</a> </div></a> </div> </div> </div> </div> </div> </div> </div> </div> <div class="newsletter-cta"> <h2 class="heading">Subscribe to our newsletter</h2> <div class="message"> Sign up for our monthly Newsletter to keep up with all things NextGen Biomed </div> <div class="button-wrapper"> <a href="#" class="button hs-cta-trigger-button hs-cta-trigger-button-177053686099">Newsletter Sign-Up</a> </div> </div> </main> <div data-global-resource-path="git/og-stage/templates/partials/footer.html"><footer class="website-footer flex flex-column g-20"> <div class="footer-columns"> <div class="footer-column"> <a href="https://oxfordglobal.com" class="site-logo-link"> <img src="https://oxfordglobal.com/wp-content/uploads/2023/03/Oxford-Global-Logo-Stacked-Websize.png" class="site-logo"> </a> </div> <div class="footer-column"> <h3>Brands</h3> <ul> <li> <a href="/precision-medicine/">Precision Medicine</a> </li> <li> <a href="/discovery-development/">Discovery &amp; Development</a> </li> <li> <a href="/nextgen-biomed/">NextGen Biomed</a> </li> </ul> </div> <div class="footer-column"> <h3>Services</h3> <ul> <li> <a href="https://oxfordglobal.com/in-person-services/"> In-Person Services </a> </li> <li> <a href="https://oxfordglobal.com/digital-marketing-services/"> Digital Marketing Services </a> </li> </ul> <h3>Upcoming Events</h3> <ul> <li> <a href="https://oxfordglobal.com/calendar/"> Event Calendar </a> </li> </ul> </div> <div class="footer-column"> <h3>Company</h3> <ul> <li class="elementor-icon-list-item"> <a href="https://oxfordglobal.com/about-us/"> About </a> </li> <li class="elementor-icon-list-item"> <a href="https://oxfordglobal.com/vacancies/"> Vacancies </a> </li> <li class="elementor-icon-list-item"> <a href="https://oxfordglobal.com/csr-policy/"> CSR Policy </a> </li> <li class="elementor-icon-list-item"> <a href="javascript:postMessage({type:'HS_DISPLAY_CALL_TO_ACTION',id:130207947529});"> Contact </a> </li> </ul> </div> <div class="footer-column"> <p> <a href="tel:+441865248455">+44 1865 248 455</a><br> <a href="mailto:help@oxfordglobal.com">help@oxfordglobal.com</a> </p> <p> <strong>Our UK Address:</strong><br> Godstow Court<br> Minns Business Park<br> Botley<br> Oxford, OX2 0JB </p> <p> <strong>Our US Address:</strong><br> 100 Cambridge Street<br> 14th Floor<br> Boston<br> MA 02114 </p> </div> </div> <div class="footer-bottom grid g-20"> <div class="span8 span12-sm span12-md flex flex-column g-10"> <div class="copyright"> © Oxford Global Marketing Ltd. All rights reserved. </div> <ul class="legal-links flex flex-row g-30 flex-column-sm g-sm-10"> <li><a href="https://oxfordglobal.com/legal/">Terms &amp; Conditions</a></li> <li><a href="https://oxfordglobal.com/legal/privacy-policy/">Privacy Policy</a></li> <li><a href="https://oxfordglobal.com/legal/website-terms/">Cookies</a></li> <li><a href="https://www.wishagency.co.uk/" target="_BLANK">Digital Agency Wish</a></li> </ul> </div> <div class="span4 span12-sm span12-md flex-align-end"> <ul class="social-links flex flex-row flex-justify-end flex-justify-center-sm flex-justify-center-md g-30"> <li><a href="https://www.facebook.com/OGConferences/" target="_BLANK"><i class="fa-brands fa-square-facebook"></i></a></li> <li><a href="https://www.linkedin.com/company/oxford-global/" target="_BLANK"><i class="fa-brands fa-linkedin"></i></a></li> <li><a href="https://twitter.com/OGConferences" target="_BLANK"><i class="fa-brands fa-square-x-twitter"></i></a></li> </ul> </div> </div> </footer></div> </div> <script src="/hs/hsstatic/jquery-libs/static-1.1/jquery/jquery-1.7.1.js"></script> <script>hsjQuery = window['jQuery'];</script> <!-- HubSpot performance collection script --> <script defer src="/hs/hsstatic/content-cwv-embed/static-1.1293/embed.js"></script> <script src="https://oxfordglobal.com/hs-fs/hub/8696823/hub_generated/template_assets/182600797781/1731148644227/git/og-stage/js/inlineSVG.min.js"></script> <script src="https://oxfordglobal.com/hs-fs/hub/8696823/hub_generated/template_assets/135724366742/1725380923802/git/og-stage/js/main.min.js"></script> <script> function getVideoId(url) { var regExp = /^.*(youtu.be\/|v\/|u\/\w\/|embed\/|watch\?v=|\&v=)([^#\&\?]*).*/; var match = url.match(regExp); if (match && match[2].length == 11) { return match[2]; } else { return false; } } function getVideoEmbed(id) { return '<iframe src="https://www.youtube.com/embed/' + id + '" title="YouTube video player" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" allowfullscreen style="aspect-ratio: 16 / 9; width: 100%;"></iframe>'; } jQuery("div.content-body .wp-block-embed__wrapper:contains('youtu')").each(function() { var yt_url = $(this).html().trim(); var yt_id = getVideoId(yt_url); var yt_embed = getVideoEmbed(yt_id); $(this).html(yt_embed); }); </script> <!-- Start of HubSpot Analytics Code --> <script type="text/javascript"> var _hsq = _hsq || []; _hsq.push(["setContentType", "standard-page"]); _hsq.push(["setCanonicalUrl", "https:\/\/oxfordglobal.com\/nextgen-biomed\/resources\/the-black-box-effect"]); _hsq.push(["setPageId", "hubdb-177607186815-30817717-181072999314"]); _hsq.push(["setContentMetadata", { "contentPageId": "hubdb-177607186815-30817717-181072999314", "legacyPageId": "hubdb-177607186815-30817717-181072999314", "contentFolderId": null, "contentGroupId": null, "abTestId": null, "languageVariantId": 177607186815, "languageCode": "en", }]); </script> <script type="text/javascript" id="hs-script-loader" async defer src="/hs/scriptloader/8696823.js"></script> <!-- End of HubSpot Analytics Code --> <script type="text/javascript"> var hsVars = { render_id: "d2a90092-0321-4e4b-9a44-db360240b7c3", ticks: 1732368472386, page_id: 177607186815, dynamic_page_id: "hubdb-177607186815-30817717-181072999314", content_group_id: 0, portal_id: 8696823, app_hs_base_url: "https://app.hubspot.com", cp_hs_base_url: "https://cp.hubspot.com", language: "en", analytics_page_type: "standard-page", scp_content_type: "", analytics_page_id: "hubdb-177607186815-30817717-181072999314", category_id: 1, folder_id: 0, is_hubspot_user: false } </script> <script defer src="/hs/hsstatic/HubspotToolsMenu/static-1.354/js/index.js"></script> </body></html>

Pages: 1 2 3 4 5 6 7 8 9 10